612 related articles for article (PubMed ID: 15707281)
41. The use of the copepod Mesocyclops longisetus as a biological control agent for Aedes aegypti in Cali, Colombia.
Suárez-Rubio M; Suárez ME
J Am Mosq Control Assoc; 2004 Dec; 20(4):401-4. PubMed ID: 15669381
[TBL] [Abstract][Full Text] [Related]
42. Laboratory evaluation of Vectobac as against Aedes aegypti in Monterrey, Nuevo León, Mexico.
Ponce G G; Flores AE; Badii MH; Rodríguez-Tovar ML; Fernández-Salas I
J Am Mosq Control Assoc; 2002 Dec; 18(4):341-3. PubMed ID: 12545970
[TBL] [Abstract][Full Text] [Related]
43. Efficacy of Bacillus thuringiensis (H-14) for larval Aedes mosquito control in intermountain meadows in Wyoming.
Jones CJ; Lloyd JE
J Am Mosq Control Assoc; 1985 Mar; 1(1):51-5. PubMed ID: 3880213
[TBL] [Abstract][Full Text] [Related]
44. Toxicity in carcasses of Bacillus thuringiensis var. israelensis-killed Aedes aegypti larvae against scavenging larvae: implications to bioassay.
Zaritsky A; Khawaled K
J Am Mosq Control Assoc; 1986 Dec; 2(4):555-9. PubMed ID: 3507532
[No Abstract] [Full Text] [Related]
45. Efficacy of native cyclopoid copepods in biological vector control with regard to their predatory behavior against the Asian tiger mosquito, Aedes albopictus.
Pauly I; Jakoby O; Becker N
Parasit Vectors; 2022 Oct; 15(1):351. PubMed ID: 36183110
[TBL] [Abstract][Full Text] [Related]
46. A semifield evaluation of Vectobac DT (ABG-6499), a new formulation of Bacillus thuringiensis israelensis for control of Aedes albopictus.
Toma L; Severini F; Bella A; Romi R
J Am Mosq Control Assoc; 2003 Dec; 19(4):424-9. PubMed ID: 14710747
[TBL] [Abstract][Full Text] [Related]
47. Long-term exposure of Aedes aegypti to Bacillus thuringiensis svar. israelensis did not involve altered susceptibility to this microbial larvicide or to other control agents.
Carvalho KDS; Crespo MM; Araújo AP; da Silva RS; de Melo-Santos MAV; de Oliveira CMF; Silva-Filha MHNL
Parasit Vectors; 2018 Dec; 11(1):673. PubMed ID: 30594214
[TBL] [Abstract][Full Text] [Related]
48. Effect of inactivation by sunlight on the larvicidal activities of mosquitocidal Bacillus thuringiensis H-14 isolates from Nigerian soils.
Obeta JA
J Commun Dis; 1996 Jun; 28(2):94-100. PubMed ID: 8810143
[TBL] [Abstract][Full Text] [Related]
49. [Influence of biotic factors on the efficacy of Bacillus thuringiensis var. Israelensis against Aedes aegypti (Diptera: Culicidae)].
Corbillón Porraspita CO; González Rizo A; Menéndez Díaz Z; Companioni Ibañez A; Bruzón Aguila RY; Díaz Pérez M; Gato Armas R
Rev Cubana Med Trop; 2012; 64(3):235-43. PubMed ID: 23424800
[TBL] [Abstract][Full Text] [Related]
50. Efficacy of a Bacillus thuringiensis israelensis tablet formulation, vectobac DT, for control of dengue mosquito vectors in potable water containers.
Benjamin S; Rath A; Fook CY; Lim LH
Southeast Asian J Trop Med Public Health; 2005 Jul; 36(4):879-92. PubMed ID: 16295540
[TBL] [Abstract][Full Text] [Related]
51. [Characterization of Bacillus thuringrensis var. israelesis larvicide granules to larvae of mosquitoes].
Xu J; Zhao S; Liu Q; Qi JH; Li CM; Wang Y; Sun J; Han GJ; Ma TB
Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2013 Feb; 25(1):52-5. PubMed ID: 23687813
[TBL] [Abstract][Full Text] [Related]
52. Integrated use of planaria (Dugesia dorotocephala) and Bacillus thuringiensis var. israelensis against Aedes taeniorhynchus: a laboratory bioassay.
Perich MJ; Clair PM; Boobar LR
J Am Mosq Control Assoc; 1990 Dec; 6(4):667-71. PubMed ID: 2098475
[TBL] [Abstract][Full Text] [Related]
53. Mesocyclops brevisetosus (Cyclopoida: Cyclopoidae) as a potential biological control agent against mosquito larvae in Indonesia.
Gionar YR; Atmosoedjono S; Bangs MJ
J Am Mosq Control Assoc; 2006 Sep; 22(3):437-43. PubMed ID: 17067043
[TBL] [Abstract][Full Text] [Related]
54. Laboratory evaluation of Bacillus thuringiensis var. israelensis serotype H-14 against mosquito larvae with particular reference to Aedes aegypti.
Sharma SK; Wattal BL; Mathur KK
J Commun Dis; 1982 Jun; 14(2):106-10. PubMed ID: 7153478
[No Abstract] [Full Text] [Related]
55. Field trials of three concentrations of Laginex as biological larvicide compared to Vectobac-12AS as a biocontrol agent for Culex quinquefasciatus.
Hallmon CF; Schreiber ET; Vo T; Bloomquist A
J Am Mosq Control Assoc; 2000 Mar; 16(1):5-8. PubMed ID: 10757483
[TBL] [Abstract][Full Text] [Related]
56. Susceptibility of field-collected Aedes aegypti (L.) (Diptera: Culicidae) to Bacillus thuringiensis israelensis and temephos.
Loke SR; Andy-Tan WA; Benjamin S; Lee HL; Sofian-Azirun M
Trop Biomed; 2010 Dec; 27(3):493-503. PubMed ID: 21399591
[TBL] [Abstract][Full Text] [Related]
57. Control of Aedes albopictus larvae using time-release larvicide formulations in Louisiana.
Nasci RS; Wright GB; Willis FS
J Am Mosq Control Assoc; 1994 Mar; 10(1):1-6. PubMed ID: 7516963
[TBL] [Abstract][Full Text] [Related]
58. Laboratory evaluation of Bacillus thuringiensis H-14 against Aedes aegypti larvae in the northeast region of Thailand.
Pipitgool V; Maleewong W; Daenseegaew W; Thaiklar K
Southeast Asian J Trop Med Public Health; 1991 Sep; 22(3):426-8. PubMed ID: 1818396
[TBL] [Abstract][Full Text] [Related]
59. Laboratory bioassay to compare susceptibilities of Aedes aegypti and Anopheles albimanus to Bacillus thuringiensis var. israelensis as affected by their feeding rates.
Mahmood F
J Am Mosq Control Assoc; 1998 Mar; 14(1):69-71. PubMed ID: 9599326
[TBL] [Abstract][Full Text] [Related]
60. Laboratory and field evaluation of Teknar HP-D, a biolarvicidal formulation of Bacillus thuringiensis ssp. israelensis, against mosquito vectors.
Gunasekaran K; Doss PS; Vaidyanathan K
Acta Trop; 2004 Oct; 92(2):109-18. PubMed ID: 15350862
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
